However, prior studies in murine models of SLE using gene-targeted Cr2−/− mice, which lack both CR2 and complement receptor 1 (CR1/CD35), demonstrated variable results, possibly due to the associated lack of interactions by C4b itself with CR1 being a dominant effect (Einav et al., 2002). This evidence concerns the gene C4B and systemic lupus erythematosus.